PET-CT imaging with [18 F]fluorodeoxyglucose (FDG) and [18 F]fluorocholine (FCH) altered treatment plans in only a tiny ...

A BRAVE mum-of-four says she is going to "fight as long as she can" after receiving a "devastating" cancer diagnosis. Zoe Harris, aged 45, was told she had an "aggressive" liver cancer earlier this ...

Adjusted analyses showed that people with the greatest adherence to the Mediterranean diet had a modest 6% lower risk for ...

Bariatric surgery reduces the progression to decompensated cirrhosis and the risk for major adverse liver outcomes, such as ...

A Whakatāne man with terminal cancer says he has outlived his life expectancy after joining a trial for cancer drugs that ...

The leading Advanced Merkel Cell Carcinoma Companies such as Xencor, Inc., Incyte Corporation, Millennium Pharmaceuticals, ...

Metabolic surgery significantly lowered risk for major adverse liver outcomes vs. nonsurgical management among patients with obesity and compensated cirrhosis from metabolic dysfunction-associated ...

为解决肝细胞癌（HCC）预后差、缺乏有效生物标志物的问题，研究人员开展了 RECQL4 在 HCC 中作用的研究，发现其可预测预后、影响药物敏感性，对 HCC 治疗意义重大。 肝细胞癌（Hepatocellular carcinoma，HCC），这个隐匿在人体肝脏内的 “健康杀手”，一直以来都是全球癌症领域的一大难题。它不仅是全球第六大常见癌症，更是癌症相关死亡的第三大主因。多数 HCC ...

为解决肝细胞癌（HCC）患者等待肝移植期间肿瘤进展问题，相关研究人员开展 Histotripsy 作为桥接治疗的研究，发现其可使肿瘤完全坏死，为 HCC 治疗提供新选择。

NAYA Biosciences, Inc. ("NAYA") (NASDAQ: NAYA), a life science portfolio company dedicated to bringing breakthrough treatments to patients ...

More than 67,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.